|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization expense | |||
| Amortization of operating lease right-of-use assets | |||
| Stock-based compensation expense | |||
| Accretion of discounts on marketable securities | |||
| Loss on disposal of property and equipment | |||
| Loss on termination of operating lease | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Prepaid expenses and other current assets | |||
| Accounts payable | |||
| Accrued expenses | |||
| Accrued restructuring expenses | |||
| Deferred revenue | |||
| Deferred offering costs | |||
| Other assets | |||
| Operating lease liabilities | |||
| Other liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Purchases of property and equipment | |||
| Sales and maturities of marketable securities | |||
| Proceeds from sale of equipment | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of common stock under at-the market offering of common stock, net of issuance costs | |||
| Proceeds from follow-on public offering of common stock, net of issuance costs | |||
| Initial Public Offering | |||
| Follow-on Offering | |||
| Total proceeds from follow-on public offering of common stock, net of issuance costs | |||
| Payment of public offering costs | |||
| Proceeds from issuance of convertible preferred stock, net of issuance costs paid in the period | |||
| Payments of issuance costs of convertible preferred stock issued in prior period | |||
| Payment of issuance costs | |||
| Convertible Preferred Stock | |||
| Total payment of issuance costs | |||
| Proceeds from issuance of common stock under employee stock purchase plan | |||
| Proceeds from exercise of stock options | |||
| Net cash provided by financing activities | |||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash at beginning of period | |||
| Cash, cash equivalents and restricted cash at end of period | |||
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Conversion of convertible preferred stock into common stock | |||
| Lease assets obtained in exchange for operating lease liabilities | |||
| Initial public offering costs included in accounts payable and accrued expenses at end of period | |||
| Reduction in lease assets and liabilities due to lease amendment |
Loading...
